Form 4: CVS Executive Sells Shares for Tax Obligations

CVS Health Corp's SVP, Controller & Chief Accounting Officer, James David Clark, disposed of 220 restricted common shares to cover FICA tax obligations.

Summary

• James David Clark, SVP, Controller & Chief Accounting Officer of CVS Health Corp, reported a transaction on December 1, 2025.
• The transaction involved the disposal of 220 shares of Common Stock (Restricted).
• The shares were disposed of at a price of $79.1 per share.
• The total value of the disposed shares is approximately $17,402 (220 shares * $79.1/share).
• This disposal was a withholding of shares by the Issuer to satisfy FICA taxes, as the reporting person is retirement eligible.
• Following this transaction, James David Clark beneficially owns 24,401 shares of Common Stock (Restricted).

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary disposal of shares for tax purposes, which is a neutral event for the company's stock performance or operational outlook.

Positives

• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary sale for tax purposes.

Negatives

• A reduction in the insider's direct beneficial ownership of 220 shares.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This routine insider transaction, specifically for tax purposes, does not provide insights into broader industry trends or competitive landscape for the healthcare or pharmacy retail sector.

Stakeholder Impact

• Shareholders: Minimal impact due to the small number of shares involved and the routine nature of the tax-related disposal.
• Employees: No direct impact on employees.
• Customers: No direct impact on customers.
• Suppliers: No direct impact on suppliers.
• Creditors: No direct impact on creditors.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of a small number of shares by an executive to cover tax obligations. Such a transaction is common and does not reflect a change in the company's fundamentals, strategic direction, or the executive's confidence in the company. Therefore, it provides no new information that would warrant a change in an existing investment thesis, leading to a 'hold' recommendation based solely on this filing.

Keywords

CVS Health Corp, CVS, Form 4, Insider Transaction, Stock Sale, Executive Compensation, Tax Withholding, James David Clark, Restricted Stock, FICA